Inactivated influenza vaccine with adjuvant

2 marketed

This page covers all Inactivated influenza vaccine with adjuvant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Influenza virus hemagglutinin and neuraminidase antigens; MF59 acts as immunological adjuvant.

Targets

Influenza virus hemagglutinin and neuraminidase antigens; MF59 acts as immunological adjuvant

Marketed (2)